Epidemiology and genetic determinants of progressive deterioration of glycaemia in American Indians: The Strong Heart Family Study

Diabetologia

Volumn 56, Issue 10, 2013, Pages 2194-2202

  Franceschini, N ^a   Haack, K ^b   Goring H H H ^b   Voruganti, V S ^b   Laston, S ^b   Almasy, L ^b   Lee, E T ^c   Best, L G ^d   Fabsitz, R R ^e   North, K E ^a   MacCluer, J W ^b   Meigs, J B ^f,g   Pankow, J S ^h   Cole, S A ^b  

^a IL   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d Missouri Breaks Industry Research   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Heritability; Impaired fasting glucose; Single nucleotide polymorphisms; Type 2 diabetes

Indexed keywords

GLUCOSE;

ADULT; AMERICAN INDIAN; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HERITABILITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THADA GENE; TSPAN8 GENE; WFS1 GENE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84890115816     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2988-8     Document Type: Article

References (49)

1. American Diabetes Association (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34(suppl 1):S62-S69
2. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
3. Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802-1812
4. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929
5. Godsland IF, Jeffs JA, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157-1166
6. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794
7. Gabir MM, Hanson RL, Dabelea D et al (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23:1108-1112
8. Edelstein SL, Knowler WC, Bain RP et al (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46:701-710
9. de Vegt F, Dekker JM, Jager A et al (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285:2109-2113
10. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Riccardi G (1999) Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care 22:1490-1493
11. Cowie CC, Rust KF, Byrd-Holt DD et al (2006) Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 29:1263-1268
12. Harris MI, Flegal KM, Cowie CC et al (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-524
13. Wang H, Shara NM, Calhoun D, Umans JG, Lee ET, Howard BV (2010) Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study. Diabetes Metab Res Rev 26:378-385
14. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R (2003) The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 52:1475-1484
15. Haffner SM (1998) Epidemiology of type 2 diabetes: risk factors. Diabetes Care 21(suppl 3):C3-C6
16. Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544
17. Walker KZ, O'Dea K, Gomez M, Girgis S, Colagiuri R (2010) Diet and exercise in the prevention of diabetes. J Hum Nutr Diet 23:344-352
18. Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350
19. Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
20. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289-297
21. Hivert MF, Jablonski KA, Perreault L et al (2011) Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 60:1340-1348
22. Pierce M, Keen H, Bradley C (1995) Risk of diabetes in offspring of parents with non-insulin-dependent diabetes. Diabet Med 12:6-13
23. Kaprio J, Tuomilehto J, Koskenvuo M et al (1992) Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060-1067
24. Hemminki K, Li X, Sundquist K, Sundquist J (2010) Familial risks for type 2 diabetes in Sweden. Diabetes Care 33:293-297
25. Rung J, Cauchi S, Albrechtsen A et al (2009) Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 41:1110-1115
26. Cho YS, Chen CH, Hu C et al (2011) Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44:67-72
27. Voight BF, Scott LJ, Steinthorsdottir V et al (2012) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579-589
28. McCarthy MI (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363:2339-2350
29. Prokopenko I, McCarthy MI, Lindgren CM (2008) Type 2 diabetes: new genes, new understanding. Trends Genet 24:613-621
30. Wolfs MG, Hofker MH, Wijmenga C, van Haeften TW (2009) Type 2 diabetes mellitus: new genetic insights will lead to new therapeutics. Curr Genomics 10:110-118
31. Walford GA, Green T, Neale B et al (2012) Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism. Diabetologia 55:331-339
32. North KE, Williams JT, Welty TK et al (2003) Evidence for joint action of genes on diabetes status and CVD risk factors in American Indians: the strong heart family study. Int J Obes Relat Metab Disord 27:491-497
33. Lee ET, Welty TK, Fabsitz R et al (1990) The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 132:1141-1155
34. Storti KL, Arena VC, Barmada MM et al (2009) Physical activity levels in American-Indian adults: the Strong Heart Family Study. Am J Prev Med 37:481-487
35. (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
36. Haiman CA, Fesinmeyer MD, Spencer KL et al (2012) Consistent directions of effect for established type 2 diabetes risk variants across populations: the population architecture using Genomics and Epidemiology (PAGE) Consortium. Diabetes 61:1642-1647
37. Buyske S, Wu Y, Carty CL et al (2012) Evaluation of the metabochip genotyping array in African Americans and implications for fine mapping of GWAS-identified loci: the PAGE study. PLoS One 7:e35651
38. Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211
39. Tenesa A, Haley CS (2013) The heritability of human disease: estimation, uses and abuses. Nat Rev Genet 14:139-149
40. Hanson RL, Elston RC, Pettitt DJ, Bennett PH, Knowler WC (1995) Segregation analysis of non-insulin-dependent diabetes mellitus in Pima Indians: evidence for a major-gene effect. Am J Hum Genet 57:160-170
41. Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638-645
42. Guo T, Hanson RL, Traurig M et al (2007) TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals. Diabetes 56:3082-3088
43. Cheurfa N, Brenner GM, Reis AF et al (2011) Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study. Diabetologia 54:554-562
44. Rong R, Hanson RL, Ortiz D et al (2009) Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes 58:478-488
45. Dunham I, Kundaje A, Aldred SF et al (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74
46. Malhotra A, Kobes S, Knowler WC, Baier LJ, Bogardus C, Hanson RL (2011) A genome-wide association study of BMI in American Indians. Obesity (Silver Spring) 19:2102-2106
47. Hanson RL, Bogardus C, Duggan D et al (2007) A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes 56:3045-3052
48. Lloyd-Jones DM, Hong Y, Labarthe D et al (2010) Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 121:586-613
49. American Diabetes Association (2013) Executive summary: standards of medical care in diabetes-2013. Diabetes Care 36(suppl 1):S4-S10